For teams advancing novel ocular therapies, one of the biggest challenges is finding a CRO that can offer both deep scientific expertise and predictable study execution. That is exactly where we can help!

Experimentica will be attending the partnering event at BIO-Europe Spring 2026 in Lisbon, Portugal on 23 – 25 March to connect with companies looking for a reliable and science‑driven partner in preclinical ocular disease models. During partnering, we are available to discuss:
• Selecting the right ocular models for early‑stage decision‑making
• Designing studies that reduce risk before IND‑enabling steps
• Our capabilities in in vivo imaging, functional assessment, histology and biomolecular analyses

If you are planning your next preclinical study or exploring a new therapy area, let’s connect! Book a partnering meeting via the event platform or reach out directly to Guillaume Demarne or Giedrius Kalesnykas.

Guillaume Demarne

Guillaume Demarne

, PharmD

Chief Business Officer